Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M540Revenue $M14.8Net Margin (%)-213.0Altman Z-Score13.8
Enterprise Value $M386EPS $-0.5Operating Margin %-290.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.5Pre-tax Margin (%)-212.4Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %-16.8Quick Ratio11.2Cash flow > EarningsN
Price/Sales32.65-y EBITDA Growth Rate %-5.0Current Ratio11.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-21.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-24.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M72.1ROIC % (ttm)-226.7Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOFirst Eagle Investment 2014-03-31 Sold Out $9.76 - $15.28
($11.96)
$ 7.49-37%Sold Out0
INOFirst Eagle Investment 2013-12-31 Buy $6.92 - $11.88
($8.34)
$ 7.49-10%New holding62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENITO SIMON XDirector 2015-08-14Buy6,000$7.213.88 view
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-21.41 view
KIES PETERCFO 2014-10-09Buy3,960$10.1-25.84 view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-25.17 view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-23.1 view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.06-17.33 view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.7-13.91 view
Kim Jong JosephCEO 2014-04-15Buy6,250$9-16.78 view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.282.88 view
Bagarazzi MarkChief Medical Officer 2013-04-16Buy15,000$2.24234.38 view

Press Releases about INO :

Quarterly/Annual Reports about INO:

    News about INO:

    Articles On GuruFocus.com
    Inovio Pharmaceuticals' CEO Dr. J. Joseph Kim Interviewed by The Life Sciences Report Oct 30 2014 
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
    comment on INO May 10 2013 
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    Any opinions regarding Apr 12 2010 

    More From Other Websites
    How Does Novavax Compare to Its Competitors? Aug 31 2015
    Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio... Aug 29 2015
    Inovio Pharmaceuticals to Participate in Citi and Rodman & Renshaw Investor Conferences Aug 26 2015
    Inovio Pharmaceuticals to Participate in Citi and Rodman & Renshaw Investor Conferences Aug 26 2015
    INOVIO PHARMACEUTICALS, INC. Financials Aug 21 2015
    Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio Aug 21 2015
    Inovio Reports Encouraging Preclinical Data on DNA Vaccine Aug 20 2015
    Sentiment for Advaxis Back to Bullish With Broadfin and Inovio Deal Aug 20 2015
    Inovio Pharmaceuticals DNA Vaccine Protects 100% Against Deadly MERS Virus in Non-Human Primates Aug 20 2015
    Inovio Pharmaceuticals DNA Vaccine Protects 100% Against Deadly MERS Virus in Non-Human Primates Aug 19 2015
    Is this CEO going to take on Trump? Aug 14 2015
    Corporate Document-Corporate Profile for Inovio Pharmaceuticals, Inc. Aug 13 2015
    INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 12 2015
    MedImmune Deal Validates Inovio's Cancer Tech Aug 11 2015
    Inovio Q2 Loss Wider-than-Expected, Deal with AstraZeneca - Analyst Blog Aug 11 2015
    Jim Cramer's Top Takeaways: Radius Health, Inovio Pharmaceuticals Aug 11 2015
    Jim Cramer's 'Mad Money' Recap: 10 Things That Created Today's Market Rally Aug 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK